In this study, we employed the gain and loss of function strategies to determine the roles of POU2F1 and/or ALDOA in the glucose metabolism, proliferation and drug resistance of colon cancer in vitro and in vivo. This evidence concerns the gene ALDOA and malignant colon neoplasm.